Abstract
Alterations of the human MSH2 gene, a homologue of the bacterial MutS mismatch repair gene, co–segregate with the majority of hereditary non–polyposis colon cancer (HNPCC) cases. We have generated homozygous MSH2−/− mice. Surprisingly, these mice were found to be viable, produced offspring in a mendelian ratio and bred through at least two generations. Starting at two months of age homozygous −/− mice began, with high frequency, to develop lymphoid tumours that contained microsatellite instabilities. These data establish a direct link between MSH2 deficiency and the pathogenesis of cancer. These mutant mice should be good models to study the progression of tumours and also to screen carcinogenic and anti–cancer agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lynch, H.T. et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104, 1535–1549 (1993).
Ponz de Leon, M., Sassatelli, R., Benatti, P. & Roncucci, L. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Cancer 71, 3493–3501 (1993).
Kee, F. & Collins, B.J. How prevalent is cancer family syndrome? Gut 32, 509–512 (1991).
Cannon Albright, L.A., Skolnick, M.H., Bishop, D.T., Lee, R.G. & Burt, R.W. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. New Engl. J. Med. 319, 533–537 (1988).
Bishop, D.T. & Thomas, H.J. The genetics of colorectal cancer. Cancer Surv. 9, 585–604 (1990).
Peltomaki, P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810–812 (1993).
Lindblom, A., Tannergard, P., Werelius, B. & Nordenskjold, M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet. 5, 279–282 (1993).
Nystrom-Lahti, M. et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am. J. hum. Genet. 55, 659–665 (1994).
Fishel, R. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027–1038 (1993).
Leach, F.S. et al. Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215–1225 (1993).
Bronner, C.E. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258–261 (1994).
Papadopoulos, N. et al. Mutation of a MutL homolog in hereditary colon cancer. Science 263, 1625–1629 (1994).
Modrich, P. Mechanisms and biological effects of mismatch repair. Annu. Rev. Genet. 25, 229–253 (1991).
Fishel, R. & Kolodner, R.D. Identification of mismatch repair genes and their role in development of cancer. Curr. Opin. Genet. Dev. 5, 382–395 (1995).
Nicolaides, N.C. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371, 75–80 (1994).
Parsons, R., Longley, M., Kinzler, K.W. & Vogelstein, B. Mismatch repair deficiency in phenotypically normal human-cells. Science 268, 738–740 (1995).
Aaltonen, L.A. et al. Clues to the pathogenesis of familial colorectal cancer. Science 260, 812–816 (1993).
Levinson, G. & Gutman, G.A. High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucl. Acids Res. 15, 5323–5338 (1987).
Strand, M., Prolla, T.A., Liskay, R.M. & Petes, T.D. Destabilization of tracts of simple repetitive DMA in yeast by mutations affecting DNA mismatch repair. Nature 365, 274–276 (1993).
Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558–561 (1993).
Thibodeau, S.N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816–819 (1993).
Risinger, J.I. et al. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res. 53, 5100–5103 (1993).
Young, J. et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mut. 2, 351–354 (1993).
Han, H.J., Yanagisawa, A., Kato, Y., Park, J.G. & Nakamura, Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 53, 5087–5089 (1993).
Peltomaki, P. et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 53, 5853–5855 (1993).
Gonzalez-Zulueta, M. et al. Microsatellite instability in bladder cancer. Cancer Res. 53, 5620–5623 (1993).
Rhyu, M.G., Park, W.S. & Meltzer, S.J. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 9, 29–32 (1994).
Wada, C. et al. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood 83, 3449–3456 (1994).
Shridhar, V., Siegfried, J., Hunt, J., del Mar Alonso, M. & Smith, D.I. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res. 54, 2084–2087 (1994).
Merlo, A. et al. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 54, 2098–2101 (1994).
Wooster, R. et al. Instability of shorttandem repeats (microsatellites) in human cancers. Nature Genet. 6, 152–156 (1994).
Yee, C.J., Roodi, N., Verrier, C.S. & Parl, F.F. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 54, 1641–1644 (1994).
Burks, R.T., Kessis, T.D., Cho, K.R. & Hedrick, L. Microsatellite instability in endometrial carcinoma. Oncogene 9, 1163–1166 (1994).
Schoenberg, M.P. et al. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun. 198, 74–80 (1994).
Honchel, R., Halling, K.C., Schaid, D.J., Pittelkow, M. & Thibodeau, S.N. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 54, 1159–1163 (1994).
Shibata, D., Peinado, M.A., Ionov, Y., Malkhosyan, S. & Perucho, M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet. 6, 273–281 (1994).
Aaltonen, L.A. et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 54, 1645–1648 (1994).
Fishel, R., Ewel, A., Lee, S., Lescoe, M.K. & Griffith, J. Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science 266, 1403–1405 (1994).
Fishel, R., Ewel, A. & Lescoe, M.K. Purified human MSH2 protein binds to DNA containing mismatched nucleotides. Cancer Res. 54, 5539–5542 (1994).
Kunkel, T.A. Nucleotide repeats. Slippery DNA and diseases. Nature 365, 207–208 (1993).
Drummond, J.T., Guo-Min, I., Longley, M.J. & Modrich, P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268, 1909–1912 (1995).
Palombo, F. et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268, 1912–1914 (1995).
Papadopoulos, N. et al. Mutations of GTBP in genetically unstable cells. Science 268, 1915–1917 (1995).
Fishel, R.A., Siegel, E.C. & Kolodner, R. Gene conversion in Escherichia coli. Resolution of heteroallelic mismatched nucleotides by co-repair. J. molec. Biol. 188, 147–157 (1986).
Feinstein, S.I. & Low, K.B. Hyper-recombining recipient strains in bacterial conjugation. Genetics 113, 13–33 (1986).
Jones, M., Wagner, R. & Radman, M. Mismatch repair and recombination in E. coli. Cell 50, 621–626 (1987).
Alani, E., Reenan, R.A. & Kolodner, R.D. Interaction between mismatch repair and genetic recombination in Saccharomyces cerevisiae. Genetics 137, 19–39 (1994).
Rayssiguier, C., Thaler, D.S. & Radman, M. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 342, 396–401 (1989).
Selva, E.M., New, L. & Lahue, R.S. Mismatch correction acts as a barrier to homeologous recombination in saccharomyces-cerevisiae. Genetics 139, 1175–1188H1 Amge (1995).
Loeb, L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
Baker, S.M. et al. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82, 302–319 (1995).
Lynch, H.T. et al. Hereditary colorectal cancer. Semin. Oncol. 18, 337–366 (1991).
Cohen, P.R. Muir-Torre syndrome in patients with hematologic malignancies. Am. J. Hemat. 40, 64–65 (1992).
Hamilton, S.R. et al. The molecular-basis of Turcots-syndrome. New Engl. J. Med. 332, 839–847 (1995).
Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227–1236 (1993).
Bhattacharyya, N.P., Skandalis, A., Ganesh, A., Groden, J. & Meuth, M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. natn. Acad. Sci. U.S.A. 91, 6319–6323 (1994).
Croce, C.M. Role of chromosome translocations in human neoplasia. Cell 49, 155–156 (1987).
Teich, N., Wyke, J., Mak, T., Bernstein, A. & Hardy, W. Pathogenesis of Retrovirous Induced Disease in RNA tumor viruses. (eds Weiss, R., Teich, N., Varmus, H. & Coffin, J.) 785–998 (Cold Spring Harbor Laboratory, Cold Spring Harbor, 1984).
Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153–1163 (1991).
Fung Leung, W.P. et al. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65, 443–449 (1991).
Bradley, A., Evans, M., Kaufman, M.H., Robertson, E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255–256 (1984).
Bradley, A. & Robertson, E. Embryo-derived stem cells: atool for elucidating the developmental genetics of the mouse. Curr. Top. Dev. Biol. 20, 357–371 (1986).
Thomas, K.R. & Capecchi, M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503–512 (1987).
Thompson, S., Clarke, A.R., Pow, A.M., Hooper, M.L., Melton, D.W. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56, 313–321 (1989).
Maniatis, T., Fritsch, E.F. & Sambrook, J. Molecular Cloning. (Cold Spring Harbor Laboratory, Cold Spring Harbor, 1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reitmair, A., Schmits, R., Ewel, A. et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11, 64–70 (1995). https://doi.org/10.1038/ng0995-64
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0995-64
This article is cited by
-
The mismatch-repair proteins MSH2 and MSH6 interact with the imprinting control regions through the ZFP57-KAP1 complex
Epigenetics & Chromatin (2022)
-
Consequences of the Hsp110DE9 mutation in tumorigenesis and the 5-fluorouracil-based chemotherapy response in Msh2-deficient mice
Cellular and Molecular Life Sciences (2022)
-
Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion and altered sensory function in mice
Scientific Reports (2016)
-
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
Nature Medicine (2015)
-
The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair
Oncogene (2014)